May. 19 at 4:29 AM
$ARCT Per Grok:
The lawsuit (Arcturus Therapeutics, Inc. v. AbbVie Inc. et al., Case No. 3:25-cv-02494, U.S. District Court for the Southern District of California) is ongoing as of mid-May 2026.
Key Developments (as of May 2026)
Defendants (AbbVie, Capstan, individual defendants) filed a motion to dismiss. The court ruled on it on March 30, 2026 (denied in part, granted in part), allowing Arcturus to file an amended complaint.
Arcturus filed its First Amended Complaint on April 13, 2026.
On May 11, 2026, defendants filed an Answer to the Amended Complaint along with Counterclaims (against Arcturus and certain individuals).
Counterclaim summons were issued on May 15, 2026.
